Assessment of psychedelic--induced states
Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)
Bibliographic Data
| ID | 5305202 |
|---|---|
| Authors | K A A Andersen (0000-0002-9313-4459, Oslo University Hospital, corresponding author), Bjørn Holmøy (0009-0008-2166-1760, Oslo University Hospital), Louis H Stewart (0000-0002-8429-2869, Østfold Hospital Trust) |
| Year | 2024 |
| Publication date | 2024-07-12 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Psychedelic Studies (JOURNAL) |
| Journal identifiers | ISSN: 2559-9283 • E-ISSN: 2559-9283 |
| Publisher | Akademiai Kiado Zrt (PUBLISHER) |
| DOI | 10.1556/2054.2024.00346 |
| OpenAlex | W4400581008 |
| Language | EN |
| References cited | 23 |
BackgroundPrevious international clinical trials have indicated that mystical experiences resulting from the consumption of classic psychedelic drugs, such as psilocybin, may represent a subjective psychological mechanism of action associated with therapeutic effects for various mental disorders. The revised 30-item Mystical Experience Questionnaire is one of several psychometric scales designed to evaluate such subjective experiences induced by psychedelic drugs. The field of psychedelic research is growing in Scandinavian countries, yet there is currently a lack of translated and culturally adapted Norwegian versions of rating scales for assessing psychedelic drug-induced states of consciousness. With planned and upcoming psychedelic research projects in Norway, there is a need for a Norwegian version of the MEQ30.AimsWe aimed to translate and adapt the Revised Mystical Experiences Questionnaire (MEQ30) from English to Norwegian.MethodsWe used rigorous translation methods, including two independent forward translations, one back-translation, pilot testing on a small psychedelic user group (n = 6) and cognitive debriefing in an expert-panel (n = 6) to ensure a culturally adapted Norwegian translation.ResultsOur translation and adaptation procedure resulted in a final Norwegian version of the MEQ30.ConclusionThe Norwegian MEQ30 is ready to be implemented in future Norwegian trials. Its psychometric properties have not yet been assessed
Debriefing · Hallucinogen · Mysticism · Norwegian · Political science · Psilocybin · Psychiatry · Applied Psychology · Chemical synthesis and alkaloids · Clinical Psychology · Psychedelics and Drug Studies · Psychology · Social Psychology
The varieties of religious experience
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
Psilocybin with psychological support for treatment-resistant depression
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression
Trial of Psilocybin versus Escitalopram for Depression
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin-assisted treatment for alcohol dependence
Epidemiology of classic psychedelic substances
A Psychometric Evaluation of the Dutch Revised Mystical Experience Questionnaire
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention
Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users
The Promise and Demise of LSD Psychotherapy in Norway
Negative mystical experiences
| Highly cited | No |
|---|